Home › Myelodysplastic Syndromes › Minnesota › Minneapolis
Pag-aaral pangklinika para sa Myelodysplastic Syndromes sa Minneapolis, MN
Isang pag-aaral para sa Myelodysplastic Syndromes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Minneapolis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
Nagre-recruitPhase 1
- Masonic Cancer Center, Minneapolis
Allo HSCT Using RIC and PTCy for Hematological Diseases
Nagre-recruitPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
Nagre-recruitPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Nagre-recruitPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Nagre-recruitPhase 1
- University of Minnesota, Minneapolis
Pag-aaral para sa Myelodysplastic Syndromes sa ibang lungsod
- Houston, TX43 pag-aaral
- Baldwin Park, CA26 pag-aaral
- New York City, NY21 pag-aaral
- Seattle, WA21 pag-aaral
- Washington, DC20 pag-aaral
- Tampa, FL19 pag-aaral
- Boston, MA19 pag-aaral
- Miami, FL17 pag-aaral
- Durham, NC14 pag-aaral
- Columbus, OH14 pag-aaral
- St. Louis, MO13 pag-aaral
- Atlanta, GA13 pag-aaral
Iba pang pag-aaral sa Minneapolis
- Non-Small Cell Lung Cancer27 pag-aaral
- Kanser sa Suso27 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Kanser sa Prostate23 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Pagkabigo ng Puso21 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
- Kanser sa Baga20 pag-aaral
- Colorectal Cancer19 pag-aaral
- Kanser ng Endometrium18 pag-aaral
- Sakit ni Parkinson17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.